Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kaufhold, Falko ^a   Zimmermann, Hanna ^a   Schneider, Elisa ^a   Ruprecht, Klemens ^a   Paul, Friedemann ^a   Oberwahrenbrock, Timm ^a   Brandt, Alexander U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY OPTIC NEUROPATHY; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INNER NUCLEAR LAYER THICKNESS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROCYSTIC MACULAR EDEMA; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NERVE DISEASE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RETINA BIPOLAR GANGLION CELL; RETINA MACULA EDEMA; RETINAL GANGLION CELL AND INNER PLEXIFORM LAYER THICKNESS; RETINAL MACULAR NERVE FIBER LAYER THICKNESS; SCANNING LASER OPHTHALMOSCOPY; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPHTHALMOSCOPY; OPTIC NEURITIS; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84881137559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071145     Document Type: Article

References (50)

1. Balcer LJ, (2006) Clinical practice. Optic neuritis. N Engl J Med 354: 1273-1280 doi:10.1056/NEJMcp053247.
2. Compston A, Coles A, (2008) Multiple sclerosis. The Lancet 372: 1502-1517 doi:10.1016/S0140-6736(08)61620-7.
3. Costello F, (2011) Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int 2011: 148394 doi:10.1155/2011/148394.
4. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, et al. (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 9: 14 doi:10.1186/1742-2094-9-14.
5. Wingerchuk DM, Weinshenker BG, (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60: 848-853.
6. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, et al. (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Annals of Neurology 58: 383-391 doi:10.1002/ana.20575.
7. Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, et al. (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72: 1077-1082 doi:10.1212/01.wnl.0000345042.53843.d5.
8. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, et al. (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. The Lancet Neurology 9: 921-932 doi:10.1016/S1474-4422(10)70168-X.
9. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, et al. (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59: 963-969 doi:10.1002/ana.20851.
10. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, et al. (2009) Optical Coherence Tomography Helps Differentiate Neuromyelitis Optica and MS Optic Neuropathies. Neurology 73: 302-308 doi:10.1212/WNL.0b013e3181af78b8.
11. Bock M, Brandt AU, Dörr J, Kraft H, Weinges-Evers N, et al. (2010) Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clinical Neurology and Neurosurgery. 112: 647-652 doi:10.1016/j.clineuro.2010.04.014.
12. Burkholder BM, Osborne B, Loguidice MJ, Bisker E, Frohman TC, et al. (2009) Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis. Arch Neurol 66: 1366-1372 doi:10.1001/archneurol.2009.230.
13. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, et al. (2012) Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS ONE 7: e36847 doi:10.1371/journal.pone.0036847.
14. Oberwahrenbrock T, Schippling S, Ringelstein M, Kaufhold F, Zimmermann H, et al. (2012) Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography. Multiple Sclerosis International 2012: 1-10 doi:10.1155/2012/530305.
15. De Seze J, Blanc F, Jeanjean L, Zéphir H, Labauge P, et al. (2008) Optical coherence tomography in neuromyelitis optica. Arch Neurol 65: 920-923 doi:10.1001/archneur.65.7.920.
16. Talman LS, Bisker ER, Sackel DJ, Long Jr DA, Galetta KM, et al. (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Annals of Neurology 67: 749-760 doi:10.1002/ana.22005.
17. Brandt AU, Oberwahrenbrock T, Ringelstein M, Young KL, Tiede M, et al. (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134: e193; author reply e194. doi:10.1093/brain/awr095.
18. Zimmermann H, Freing A, Kaufhold F, Gaede G, Bohn E, et al. (2013) Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 19: 443-450 doi:10.1177/1352458512457844.
19. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, et al. (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134: 518-533 doi:10.1093/brain/awq346.
20. Seigo M, Sotirchos E, Newsome S, Babiarz A, Eckstein C, et al. (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 259: 2119-2130 doi:10.1007/s00415-012-6466-x.
21. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, et al. (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135: 521-533 doi:10.1093/brain/awr264.
22. Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, et al. (2011) The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS ONE 6: e22947 doi:10.1371/journal.pone.0022947.
23. Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, et al. (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler. doi: 10.1177/1352458513489757.
24. Bock M, Brandt AU, Dorr J, Pfueller CF, Ohlraun S, et al. (2010) Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study. Multiple Sclerosis 16: 893-896 doi:10.1177/1352458510365156.
25. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ, (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135: 1786-1793 doi:10.1093/brain/aws098.
26. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, et al. (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11: 963-972 doi:10.1016/S1474-4422(12)70213-2.
27. Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, et al. (2013) In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 80: 1406-1414 doi:10.1212/WNL.0b013e31828c2f7a.
28. Gelfand JMCB (2013) Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol: 1-5. doi:10.1001/jamaneurol.2013.1832.
29. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R, (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133: 1591-1601 doi:10.1093/brain/awq080.
30. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
31. Balk LJ, Killestein J, Polman CH, Uitdehaag BMJ, Petzold A (2012) Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain 135: e226; author reply e227. doi:10.1093/brain/aws216.
32. Barboni P, Carelli V, Savini G, Carbonelli M, La Morgia C, et al. (2013) Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. doi:10.1093/brain/awt014.
33. Abegg M, Zinkernagel M, Wolf S, (2012) Microcystic macular degeneration from optic neuropathy. Brain 135: e225-e225 doi:10.1093/brain/aws215.
34. Kidd D, Burton B, Plant GT, Graham EM, (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126: 276-284.
35. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria.". Ann Neurol 58: 840-846 doi:10.1002/ana.20703.
36. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489 doi:10.1212/01.wnl.0000216139.44259.74.
37. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG, (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815 doi:10.1016/S1474-4422(07)70216-8.
38. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302 doi:10.1002/ana.22366.
39. Schneider E, Zimmermann H, Oberwahrenbrock T, Kaufhold F, Kadas EM, et al. (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS ONE. doi:10.1371/journal.pone.0066151.
40. Dinkin M, Paul F, (2013) Higher macular volume in patients with MS receiving fingolimod: positive outcome or side effect? Neurology 80: 128-129 doi:10.1212/WNL.0b013e31827ccf4a.
41. Nolan R, Gelfand JM, Green AJ, (2013) Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology 80: 139-144 doi:10.1212/WNL.0b013e31827b9132.
42. Lublin FD, Reingold SC, (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: 907-911.
43. Roxburgh RHSR, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, et al. (2005) Multiple Sclerosis Severity Score Using disability and disease duration to rate disease severity. Neurology 64: 1144-1151 doi:10.1212/01.WNL.0000156155.19270.F8.
44. Bock M, Brandt AU, Kuchenbecker J, Dörr J, Pfueller CF, et al. (2012) Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol 96: 62-67 doi:10.1136/bjo.2010.193581.
45. Tewarie P, Balk L, Costello F, Green A, Martin R, et al. (2012) The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment. PLoS ONE 7: e34823 doi:10.1371/journal.pone.0034823.
46. Albrecht P, Ringelstein M, Müller AK, Keser N, Dietlein T, et al. (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18: 1422-1429 doi:10.1177/1352458512439237.
47. Bringmann A, Wiedemann P, (2012) Müller glial cells in retinal disease. Ophthalmologica 227: 1-19 doi:10.1159/000328979.
48. Gelfand JM, Green AJ (2013) Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. doi:10.1093/brain/awt018.
49. Fairless R, Williams SK, Hoffmann DB, Stojic A, Hochmeister S, et al. (2012) Preclinical Retinal Neurodegeneration in a Model of Multiple Sclerosis. J Neurosci 32: 5585-5597 doi:10.1523/JNEUROSCI.5705-11.2012.
50. Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, et al. (2011) A population-based study of neuromyelitis optica in Caucasians. Neurology 76: 1589-1595 doi:10.1212/WNL.0b013e3182190f74.